期刊
VETERINARY JOURNAL
卷 185, 期 1, 页码 15-22出版社
ELSEVIER SCI LTD
DOI: 10.1016/j.tvjl.2010.04.008
关键词
Cancer; Stem cells; Telomerase; Biomarkers; Veterinary oncology
资金
- Pet Plan Charitable Trust
- Biotechnology and Biological Sciences Research Council
- Conacyt
- Biotechnology and Biological Sciences Research Council [BB/F008848/1] Funding Source: researchfish
- BBSRC [BB/F008848/1] Funding Source: UKRI
Despite advances in chemotherapy and radiotherapy, cancer remains a disease of high morbidity and mortality in domestic animals. In parallel to the development of novel therapeutic interventions, appropriate biomarkers are required to detect early-stage disease and disease remission and relapse at both gross and molecular levels, and the effectiveness of therapy. The field of cancer pathogenesis has grown exponentially over the last decade, both in terms of our understanding of the underlying molecular events, and the technologies available to interrogate the cancer cell. This paper reviews the role of the telomerase enzyme and of telomere length as potential biomarkers in cancer. Furthermore, the potential role of cancer stem cells as biomarkers of malignancy and disease progression is assessed. (C) 2010 Elsevier Ltd. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据